These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34807831)

  • 1. Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study.
    Paetzold I; Hermans KSFM; Schick A; Nelson B; Velthorst E; Schirmbeck F; ; van Os J; Morgan C; van der Gaag M; de Haan L; Valmaggia L; McGuire P; Kempton M; Myin-Germeys I; Reininghaus U
    JMIR Ment Health; 2021 Nov; 8(11):e30309. PubMed ID: 34807831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anhedonia in the Psychosis Risk Syndrome: State and Trait Characteristics.
    Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Poletti M; Pupo S; Raballo A
    Psychiatr Danub; 2021; 33(1):36-47. PubMed ID: 33857038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of momentary negative symptoms in patients with early psychosis in daily life: An experience sampling study.
    Fung VSC; Chan JCY; Wong SCY; Wong CSM; Kirtley O; Myin-Germeys I; Strauss GP; Chang WC
    Psychiatry Res; 2023 Jul; 325():115234. PubMed ID: 37146460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Pupo S; Gebhardt E; Raballo A
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):337-350. PubMed ID: 31055617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Nord J Psychiatry; 2021 Feb; 75(2):97-108. PubMed ID: 32762506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk Study.
    Paetzold I; Myin-Germeys I; Schick A; Nelson B; Velthorst E; Schirmbeck F; ; van Os J; Morgan C; Hartmann J; van der Gaag M; de Haan L; Valmaggia L; McGuire P; Kempton M; Reininghaus U
    Epidemiol Psychiatr Sci; 2021 May; 30():e40. PubMed ID: 34044905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis.
    Hermans KSFM; Myin-Germeys I; Gayer-Anderson C; Kempton MJ; Valmaggia L; McGuire P; Murray RM; Garety P; Wykes T; Morgan C; Kasanova Z; Reininghaus U
    Psychol Med; 2021 Nov; 51(15):2599-2609. PubMed ID: 32438944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective experience of social cognition in adolescents at ultra-high risk of psychosis: findings from a 24-month follow-up study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2020 Dec; 29(12):1645-1657. PubMed ID: 32016572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Tendency of Noncurrent Emotional Experiences in Individuals at Ultra-High Risk for Psychosis.
    Seo E; Bang M; Lee E; An SK
    Psychiatry Investig; 2018 Sep; 15(9):876-883. PubMed ID: 30176705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
    Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
    Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
    Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empathy and Its Relationship With Social Functioning in Individuals at Ultra-High Risk for Psychosis.
    Kuis DJ; van de Giessen T; de Jong S; Sportel BE; Boonstra N; van Donkersgoed R; Lysaker PH; Hasson-Ohayon I; Pijnenborg GHM
    Front Psychiatry; 2021; 12():730092. PubMed ID: 34858222
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial.
    Reininghaus U; Klippel A; Steinhart H; Vaessen T; van Nierop M; Viechtbauer W; Batink T; Kasanova Z; van Aubel E; van Winkel R; Marcelis M; van Amelsvoort T; van der Gaag M; de Haan L; Myin-Germeys I
    Trials; 2019 Dec; 20(1):769. PubMed ID: 31878966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Psychosocial Functioning and Outcome of Individuals With Recent-Onset Schizophrenia and at Ultra-High Risk for Psychosis.
    Kim HK; Park HY; Seo E; Bang M; Song YY; Lee SY; Kim KR; Park JY; Kang JI; Lee E; An SK
    Front Psychiatry; 2019; 10():459. PubMed ID: 31293463
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.